CROSSJECT’s ZENEO® needle-free auto-injector consistently matches depth of traditional intramuscular injections and exceeds the standards needle length of currently utilized auto-injectors Injection ...
July 17, 2009 — Epinephrine auto-injector needle length may be too short to reach the muscle for intramuscular delivery in a significant number of children, according to the results of a study ...
EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NYSE Amex:AIS), a leader in self-injection drug delivery technology, today announced the latest advancement in its proprietary line of VIBEX™ ...
The supplemental New Drug Application (sNDA) for the 0.1mg strength was granted Priority Review by the Food and Drug Administration (FDA). The new 0.1mg strength auto-injector has a shorter needle ...
The US Food and Drug Administration (FDA) has approved the first and only epinephrine autoinjector (EAI) specifically designed for the treatment of life-threatening allergic reactions, including ...
CROSSJECT's ZENEO® needle-free auto-injector consistently matches depth of traditional intramuscular injections and exceeds the standards needle length of currently utilized auto-injectors Injection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback